Faye Rogers, PhD, Associate Professor of Therapeutic Radiology, has been appointed Associate Cancer Center Director for Diversity, Equity, and Inclusion (DEI) at Yale Cancer Center.
Dr. Rogers’ commitment to DEI and significant experience and achievements in DEI matters make her an ideal choice to lead our program for Yale Cancer Center. As Associate Cancer Center Director for DEI, Dr. Rogers will help to ensure Yale Cancer Center is a welcoming environment and will work to develop new programs and practices that effectively increase the diversity of our faculty and staff.
Dr. Rogers will lead Yale Cancer Center’s efforts to enhance our culture of belonging, including programs and training in cultural and structural humility, counteracting stigma and stereotypes, and gender discrimination. In addition, she will lead the Yale Cancer Center Council for Diversity, Equity, and Inclusion and partner with Darin Latimore, MD, Deputy Dean and Chief Diversity Officer for Yale School of Medicine, and the leadership of Yale Cancer Center and Smilow Cancer Hospital to advance this work. I am extremely grateful to Dr. Barbara Burtness for her leadership as Interim Associate Director for DEI over the last eighteen months and look forward to her continued partnership in this area. In a short time, Dr. Burtness’ efforts have laid the foundation for a more inclusive, thoughtful Cancer Center.
At Yale School of Medicine, Dr. Rogers has been instrumental in several efforts to increase diversity within the biomedical workforce, both at the faculty and trainee levels. She currently serves as Vice Chair for DEI for the Department of Therapeutic Radiology and is respected for advancing equity both at Yale School of Medicine and nationally. Dr. Rogers is also an Associate Director of the Yale MD-PhD Program, where she actively participates in recruitment, student advisement and implementation of diversity initiatives and is Director of the Yale BioMed Amgen Scholars program, which is a research-intensive summer training program for undergraduate students from groups underrepresented in science. As director of the BioMed Amgen Scholars program, she has demonstrated her ability to work effectively and with several groups and departments across the University to successfully execute programs. Dr. Rogers also co-leads the Diversity in Research Internship Program funded by the American Cancer Society, which provides mentorship and a cancer-focused training to undergraduate students with a science major.
Beyond Yale, Dr. Rogers serves on the NIH Maximizing Access to Research Careers (MARC)/Research Training Initiative for Student Enhancement (RISE) Advisory Committee for the University of the Virgin Islands. In 2022, she was awarded the Yale Cancer Center Leadership in Diversity, Equity, and Inclusion Award. She is strongly committed to career development, mentorship, and opportunities to diversify the scientific workforce.
After receiving her PhD from the University of Maryland, Dr. Rogers completed her postdoctoral studies at Yale University in gene therapy. She leads a laboratory program studying the cellular responses at the intersection of DNA repair and apoptosis following DNA damage, with the goal of uncovering novel anticancer therapeutic strategies. Dr. Rogers received the Yale Cancer Center Translational Research Award in 2022 for her paper in the journal Nature Biotechnology, “Direct targeting of amplified gene loci for proapoptotic anticancer therapy.”